Nicholas Conn, a postdoctoral fellow at RIT and founder and CEO of Heart Health Intelligence, is part of the university team that has developed a toilet-seat based cardiovascular monitoring system.
Researchers developed the seats to measure biometrics during ‘natural’ processes
With 1 million new cases of congestive heart failure diagnosed each year, a revolutionary product is making it easier for hospitals to monitor patients with the condition in the comfort of their own homes.
A toilet-seat based cardiovascular monitoring system created by a team of Rochester Institute of Technology researchers, aims to lower the hospital readmission rates of patients with congestive heart failure. The toilet seats, which will be brought through the FDA clearance process by the researchers’ company Heart Health Intelligence, would be purchased by hospitals and issued to heart failure patients after discharge. The toilet seats are equipped to measure the electrical and mechanical activity of the heart, and can monitor heart rate, blood pressure, blood oxygenation levels, and the patient’s weight and stroke volume, which is the amount of blood pumped out of the heart at every beat. Algorithms analyze the data, and with further development, will alert advanced practice providers of a deteriorating condition. A report will be passed along to cardiologists who will then determine if intervention is necessary.
Nicholas Conn, a postdoctoral fellow at RIT and founder and CEO of Heart Health Intelligence, is part of the university team that developed the toilet seats.
“Typically, within 30 days of hospital discharge, 25 percent of patients with congestive heart failure are readmitted,” said Conn. “After 90 days of hospital discharge, 45 percent of patients are readmitted. And the Centers for Medicare and Medicaid Services is penalizing hospitals for readmitting patients for heart failure.”
Conn, the company’s chief executive officer, further explains that using the national average for readmission rates, the penalty alone for readmitting 150 patients is approximately $500,000 annually. The total cost of providing 150 patients with their own monitored toilet seats from HHI is $200,000. With that investment, he says, hospital systems will save more than double their initial investment within one year.
According to Conn, who earned three degrees from RIT—a bachelor’s degree and a master’s degree in electrical engineering in 2011 and 2013, respectively, and a doctoral degree in microsystems engineering in 2016—the system will pick up deteriorating conditions before the patients even realize they are symptomatic. And with the rapid data analysis, interventions can be as simple as a drug change or short office visit, instead of an admission to the hospital.
HHI, which joined RIT’s Venture Creations business incubator earlier this year, is now focused on moving the product forward. The team is heavily involved in writing grants for additional funding and networking, and human-subject testing and pre-clinical studies are well underway. Conn and his team are working on approving the product with the FDA and rolling it out across the country.
Learn more: Toilet seat that detects congestive heart failure getting ready to begin commercialization
The Latest on: Congestive heart failure
via Google News
The Latest on: Congestive heart failure
- Cycling Improves Heart Health of Dialysis Patientson April 9, 2021 at 5:45 am
Cycling at moderate intensity during dialysis could drastically improve the heart health of patients with kidney failure and result in savings for the NHS.
- Temple, Case Western scientists receive $3 million NIH grant to study pathway behind heart failureon April 5, 2021 at 11:12 am
Like a bad water pump that fails to circulate coolant in a car engine, a failing heart struggles to pump blood through the body, causing symptoms of fatigue, shortness of breath, and swelling in the ...
- Research lab identifies a genetic heart variant that leads to trouble for Maine Coon Catson April 5, 2021 at 11:01 am
In an effort to save her beloved animals, Kathy Janson, a Maine Coon cat enthusiast reached out to a University of Cincinnati researcher to find a way to help her pets who were developing heart ...
- Grant gives Temple, Case Western scientists chance to study pathway behind heart failureon April 4, 2021 at 9:00 pm
Scientists at the Lewis Katz School of Medicine at Temple University, in collaboration with scientists at the Case Western Reserve University School of Medicine and University Hospitals in Cleveland, ...
- Stafford man has a heart for feeding otherson April 4, 2021 at 6:04 am
He got involved with the mission in 2014, more than a year after he was diagnosed with congestive heart failure and an enlarged heart. Support our journalism. Subscribe today. Hoskins was 48 at the ...
- WATCH NOW: Stafford man has a heart for feeding otherson April 1, 2021 at 3:00 pm
Hollywood Church of the Brethren volunteer has 'such a big heart,' despite heart-related medical issues that sidelined him.
- 'It's forever for us': Couple marries at hospital after learning groom isn't eligible for heart transplanton March 31, 2021 at 10:36 am
Hospital staff organized the event, while nurses lined up chairs to make an aisle and decorated for the occasion the couple says they'll cherish forever.
- Eating just two sausages a WEEK increases your risk of heart disease and early death by up to 51%, study warnson March 31, 2021 at 5:56 am
They found a 46 per cent higher risk of major CVD events, like heart disease and stroke, as well as a 51 per cent higher risk of death among those who ate at least 150g a week of processed meat, ...
- Afraid of COVID, they skipped going to the doctor. Now their heart conditions have worsened.on March 31, 2021 at 2:00 am
When the novel coronavirus struck Louisiana last year, doctors and emergency medical workers noticed a peculiar and worrisome trend: they were seeing far fewer people suffering from heart attacks, str ...
- Drugs That Can Threaten Heart Healthon March 30, 2021 at 2:02 am
To date, two drugs have received "black box" warnings from the Food and Drug Administration for their potential to cause or worsen congestive heart failure. The FDA has restricted Avandia to people ...
via Bing News